For carriers of MSH6 and PMS2 variants there is insufficient evidence of oncological benefit to support the same approach, thus,for a first CRC, UK guidelines consider the two surgeries equal (10), whereas European guidelines advocate segmental resection unless there is a metachronous CRC (35). This evidence concerns the gene PMS2 and colorectal carcinoma.